Total operating expenses of GW Pharmaceuticals 2017-2020
In 2020, GW Pharmaceuticals spent nearly 580 million U.S. dollars on total operating expenses, which is a significant increase from around 175 million U.S. dollars spent in 2017. This statistic illustrates the total operating expenses of GW Pharmaceuticals worldwide from 2017 to 2020. In May 2021, the company was acquired by Ireland-based biopharma company Jazz Pharmaceuticals.